2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (vol 290, pg 140, 2019)

被引：1

作者：

Mach, Francois ^{[1
]}

Baigent, Colin ^{[2
]}

Catapano, Alberico L. ^{[3
]}

Koskinas, Konstantinos C. ^{[4
]}

Casula, Manuela ^{[5
,6
]}

Badimon, Lina ^{[7
]}

Chapman, M. John ^{[3
,8
,9
,13
]}

De Backer, Guy G. ^{[10
]}

Delgado, Victoria ^{[11
]}

Ference, Brian A. ^{[12
]}

Graham, Ian M. ^{[13
]}

Halliday, Alison ^{[14
]}

Landmesser, Ulf ^{[15
,16
,17
]}

Mihaylova, Borislava ^{[18
,19
,20
]}

Pedersen, Terje R. ^{[21
]}

Riccardi, Gabriele ^{[22
]}

Richter, Dimitrios J. ^{[23
]}

Sabatine, Marc S. ^{[24
,25
]}

Taskinen, Marja-Riitta ^{[26
]}

Tokgozoglu, Lale ^{[27
]}

Wiklund, Olov ^{[28
]}

Nibouche, Djamaleddine ^{[29
]}

Zelveian, Parounak H. ^{[30
]}

Siostrzonek, Peter ^{[31
]}

Najafov, Ruslan ^{[32
]}

van de Borne, Philippe ^{[33
]}

Pojskic, Belma ^{[34
]}

Postadzhiyan, Arman ^{[35
]}

Kypris, Lambros ^{[36
]}

Spinar, Jindrich ^{[37
]}

Larsen, Mogens Lytken ^{[38
]}

Eldin, Hesham Salah ^{[39
]}

Viigimaa, Margus ^{[40
]}

Strandberg, Timo E. ^{[41
]}

Ferrieres, Jean ^{[42
]}

Agladze, Rusudan ^{[43
]}

Laufs, Ulrich ^{[44
]}

Rallidis, Loukianos ^{[45
]}

Bajnok, Laszlo ^{[46
]}

Gudjonsson, Thorbjorn ^{[47
]}

Maher, Vincent ^{[48
]}

Henkin, Yaakov ^{[49
]}

Gulizia, Michele Massimo ^{[50
]}

Mussagaliyeva, Aisulu ^{[1
,51
]}

Bajraktari, Gani ^{[52
]}

Kerimkulova, Alina ^{[53
]}

Latkovskis, Gustays ^{[54
]}

Hamoui, Omar ^{[55
]}

Slapikas, Rimvydas ^{[56
]}

Visser, Laurent ^{[57
]}

机构：

[1] Geneva Univ Hosp, Dept Cardiol, 4 Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland

[2] Univ Oxford, Nuffield Dept Populat Hlth, Richard Doll Bldg,Roosevelt Dr, Oxford OX3 7LF, England

[3] Univ Milan, Dept Pharmacol & Biomol Sci, Multimed IRCCS, Via Balzaretti 9, I-20133 Milan, Italy

[4] Bern Univ Hosp, Cardiol, Inselspital, Bern, Switzerland

[5] Univ Milan, Dept Pharmacol & Biomol Sci DiSFeB, Epidemiol & Prevent Pharmacol Serv SEFAP, Milan, Italy

[6] IRCCS MultiMed, Milan, Italy

[7] IR Hosp Santa Creu & St Pau, Cardiovasc Program ICCC & CiberCV, Barcelona, Spain

[8] Sorbonne Univ, Natl Inst Hlth & Med Res, INSERM, Paris, France

[9] Pitie Salpetriere Univ Hosp, Div Endocrinol Metab, Paris, France

[10] Univ Ghent, Fac Med & Hlth Sci, Publ Hlth & Primary Care, Ghent, Belgium

[11] Leiden Univ, Med Ctr, Cardiol, Leiden, Netherlands

[12] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Naturally Randomized Trials, Cambridge, England

[13] Trinity Coll Dublin, Cardiol, Dublin, Ireland

[14] Univ Oxford, Nuffield Dept Surg, NIHR Oxford Biomed Res Ctr, Oxford, England

[15] Charite Univ Med Berlin, Dept Cardiol, Berlin, Germany

[16] Berlin Inst Hlth, Berlin, Germany

[17] German Ctr Cardiovasc Res DZHK, Berlin, Germany

[18] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England

[19] Univ Oxford, NIHR Oxford Biomed Res Ctr, Oxford, England

[20] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England

[21] Oslo Univ Hosp, Prevent Cardiol, Oslo, Norway

[22] Univ Naples Federico II, Clin Med & Surg, Naples, Italy

[23] Euroclinic, Dept Cardiac, Athens, Greece

[24] Brigham & Womens Hosp, Div Cardiovasc Med, TIMI Study Grp, 75 Francis St, Boston, MA 02115 USA

[25] Harvard Med Sch, Boston, MA 02115 USA

[26] Univ Helsinki, Res Program Clin & Mol Metab, Helsinki, Finland

[27] Hacettepe Univ, Cardiol, Ankara, Turkey

[28] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden

[29] Algerian Soc Cardiol, Algiers, Algeria

[30] Armenian Cardiologists Assoc, Yerevan, Armenia

[31] Austrian Soc Cardiol, Vienna, Austria

[32] Azerbaijan Soc Cardiol, Baku, Azerbaijan

[33] Belgian Soc Cardiol, Ixelles, Belgium

[34] Assoc Cardiologists Bosnia & Herzegovina, Sarajevo, Bosnia & Herceg

[35] Bulgarian Soc Cardiol, Sofia, Bulgaria

[36] Cyprus Soc Cardiol, Strov Nicosia, Cyprus

[37] Czech Soc Cardiol, Brno, Czech Republic

[38] Danish Soc Cardiol, Copenhagen, Denmark

[39] Egyptian Soc Cardiol, Giza, Egypt

[40] Estonian Soc Cardiol, Tallinn, Estonia

[41] Finnish Cardiac Soc, Oulu, Finland

[42] French Soc Cardiol, Paris, France

[43] Georgian Soc Cardiol, Tbilisi, Georgia

[44] German Cardiac Soc, Mannheim, Germany

[45] Hellen Soc Cardiol, Athens, Greece

[46] Hungarian Soc Cardiol, Budapest, Hungary

[47] Iceland Soc Cardiol, Reykjavik, Iceland

[48] Irish Cardiac Soc, Dublin, Ireland

[49] Israel Heart Soc, Ramat Gan, Israel

[50] Italian Federat Cardiol, Florence, Italy

来源：

ATHEROSCLEROSIS | 2020年 / 294卷

关键词：

D O I：

10.1016/j.atherosclerosis.2019.12.004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：80 / 82

页数：3

共 50 条

[21] Abbreviated lipid guidelines for clinical practiceBased on ESC lipid guidelines 2019 and ESC cardiovascular disease prevention in clinical practice guidelines 2021
Vincent Maher
Joe Gallagher
Ruth Agar
Damian Griffin
Niall Colwell
Patricia O’Connor
Brendan McAdam
Gerald Tomkin
Daphne Owens
Mary Ryan
William Tormey
Maeve Durkan
Irish Journal of Medical Science (1971 -), 2023, 192 : 2151 - 2157
[22] The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011
Ray, Kausik K.
Kastelein, John J. P.
Boekholdt, S. Matthijs
Nicholls, Stephen J.
Khaw, Kay-Tee
Ballantyne, Christie M.
Catapano, Alberico L.
Reiner, Zeljko
Luescher, Thomas F.
EUROPEAN HEART JOURNAL, 2014, 35 (15) : 960 - 968
[23] Abbreviated lipid guidelines for clinical practice Based on ESC lipid guidelines 2019 and ESC cardiovascular disease prevention in clinical practice guidelines 2021
Maher, Vincent
Gallagher, Joe
Agar, Ruth
Griffin, Damian
Colwell, Niall
O'Connor, Patricia
McAdam, Brendan
Tomkin, Gerald
Owens, Daphne
Ryan, Mary
Tormey, William
Durkan, Maeve
IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (05) : 2151 - 2157
[24] 2019 vs. 2016 ESC/EAS statin guidelines for primary prevention of atherosclerotic cardiovascular disease
Mortensen, Martin Bodtker
Nordestgaard, Borge Gronne
EUROPEAN HEART JOURNAL, 2020, 41 (31) : 3005 - 3015
[25] New Recommendations and Revised Concepts in Recent Guidelines on the Management of Dyslipidemias to Prevent Cardiovascular Disease: the 2018 ACC/AHA and 2019 ESC/EAS Guidelines
Raygor, Viraj
Khera, Amit
CURRENT CARDIOLOGY REPORTS, 2020, 22 (09)
[26] CONTROL OF CARDIOVASCULAR RISK FACTORS ACCORDING TO SCORE SYSTEM IN HYPERTENSIVE PATIENTS: ESC/EAS 2016 AND 2019 DYSLIPIDEMIA GUIDELINES COMPARISON
Sarzani, R.
Falzetti, S.
Giulietti, F.
Di Pentima, C.
Ristori, L.
Buscarini, S.
Spannella, F.
ATHEROSCLEROSIS, 2020, 315 : E177 - E178
[27] New Recommendations and Revised Concepts in Recent Guidelines on the Management of Dyslipidemias to Prevent Cardiovascular Disease: the 2018 ACC/AHA and 2019 ESC/EAS Guidelines
Viraj Raygor
Amit Khera
Current Cardiology Reports, 2020, 22
[28] 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD (vol 41, pg 255, 2019)
Ghodbhane, W.
EUROPEAN HEART JOURNAL, 2020, 41 (45) : 4317 - 4317
[29] HOW A CHANGE IN ESC/EAS GUIDELINES FOR MANAGEMENT OF DYSLIPIDAEMIAS FROM 2019 INFLUENCED THE AMOUNT OF HEALTHY INDIVIDUALS WHO SHOULD BE ELIGIBLE FOR STATIN THERAPY IN WORKING POPULATION WITH LOW RISK SCORE FOR 10-YEAR RISK OF FATAL CARDIOVASCULAR DEATH
Gilis-Januszewski, J.
Mellwig, K. P.
ATHEROSCLEROSIS, 2020, 315 : E194 - E194
[30] Does Evolocumab use in Europe match 2019 ESC/EAS lipid guidelines? Results from the HEYMANS study
Ray, K. K.
Bruckert, E.
van Hout, B.
Tepie, M. Feudjo
Bridges, I
Sibartie, M.
EUROPEAN HEART JOURNAL, 2020, 41 : 3013 - 3013

← 1 2 3 4 5 →